KW-6356

· Kyowa Kirin, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for KW-6356, covering 2018-03-20 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite [Phase 1]